title: Scleromyxedema with monoclonal gammopathy and neurological involvement: recovery from coma after plasmapheresis?
authors.forename: Aline Defaveri
authors.initials: AD
authors.lastname: do Prado
authors.forename: Deonilson
authors.initials: D
authors.lastname: Schmoeller
authors.forename: Melissa Cláudia
authors.initials: MC
authors.lastname: Bisi
authors.forename: Deise Marcela
authors.initials: DM
authors.lastname: Piovesan
authors.forename: Fernando S
authors.initials: FS
authors.lastname: Dias
authors.forename: Henrique Luiz
authors.initials: HL
authors.lastname: Staub
mesh_terms: D001927:Brain Diseases / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D003128:Coma / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D019653:Myeloablative Agonists / Q000627:therapeutic use; D010265:Paraproteinemias / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D010956:Plasmapheresis; D011241:Prednisone / Q000627:therapeutic use; D053718:Scleromyxedema / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D013792:Thalidomide / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D019653:Myeloablative Agonists; D013792:Thalidomide; D008558:Melphalan; D011241:Prednisone